Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
PaperCitations, authors & open-access status
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 263 citations, 2020 year and bronze oa status.
263
Citations
2020
Year
bronze
OA Status